The study found that the expression level of hepatic Ets-1 was elevated in a NASH mouse model as a result of the activation of transforming growth factor beta1 (TGF-β1) signaling. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.